ClinicalTrials.Veeva

Menu
C

Clinresco Centres | Kempton Park, South Africa

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Levofloxacin
Ritlecitinib
LY3009104
Baricitinib
Eravacycline

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 6 total trials

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents with Nonsegmental Vitiligo (Active and Stable) Tranquillo

Enrolling
Stable Nonsegmental Vitiligo
Active Nonsegmental Vitiligo
Drug: Ritlecitinib
Drug: Placebo

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous throm...

Active, not recruiting
Rheumatoid Arthritis
Drug: Baricitinib
Drug: TNF Inhibitor

Trial sponsors

Pfizer logo
BioNTech logo
Lilly logo
P
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems